Jens Juul Holst, Professor of Medical Physiology at the University of Copenhagen and Senior Group Leader at the Novo Nordisk Foundation Center for Basic Metabolic Research
CHICAGO Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use than those who used prednisone alone, according to an abstract presented at the CHEST Annual Meeting
Customer Satisfaction Thousands of happy buyers who trust us for their skincare journey
Its durability and central mechanism of action make it one of the most valuable tools in contemporary metabolic and obesity research
Differential pathophysiological mechanisms between CHS and EHS While CHS and EHS share core pathogenic pathways (e.g., hyperthermia, inflammation, cell death), their mechanistic features differ significantly due to distinct patient demographics and triggers: Inflammatory kinetics EHS (predominant in young, active individuals) is characterized by rapid, exertion-amplified inflammatory responses
.png)
